Cargando…

In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract

BACKGROUND AND PURPOSE: GNF-351 is a potent aryl hydrocarbon receptor (AHR) antagonist that inhibits dioxin response element-dependent and independent activities. Here, the absorption, metabolism and in vivo AHR antagonist activity of GNF-351 were investigated. EXPERIMENTAL APPROACH: LC-MS metabolom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Zhong-Ze, Krausz, Kristopher W, Nagaoka, Kenjiro, Tanaka, Naoki, Gowda, Krishne, Amin, Shantu G, Perdew, Gary H, Gonzalez, Frank J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966752/ https://www.ncbi.nlm.nih.gov/pubmed/24417285 http://dx.doi.org/10.1111/bph.12576

Ejemplares similares

Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles
por: Hubbard, Troy D., et al.
Publicado: (2015)

Urolithin A Is a Dietary Microbiota-Derived Human Aryl Hydrocarbon Receptor Antagonist
por: Muku, Gulsum E., et al.
Publicado: (2018)

The aryl hydrocarbon receptor as a mediator of host-microbiota interplay
por: Dong, Fangcong, et al.
Publicado: (2020)

Selective Ah receptor modulators attenuate NPC1L1-mediated cholesterol uptake through repression of SREBP-2 transcriptional activity
por: Muku, Gulsum E., et al.
Publicado: (2019)

Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation
por: van den Bogaard, Ellen, et al.
Publicado: (2015)

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain
por: Perkins, Arden, et al.
Publicado: (2014)

Expression of the aryl hydrocarbon receptor contributes to the establishment of intestinal microbial community structure in mice
por: Murray, Iain A., et al.
Publicado: (2016)

Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses
por: Muku, Gulsum E., et al.
Publicado: (2017)

Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells
por: Pandey, Manoj K., et al.
Publicado: (2013)

Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.
por: Zhang, Shu, et al.
Publicado: (2003)

Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity
por: Dong, Fangcong, et al.
Publicado: (2020)

Maritoclax and dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner
por: Varadarajan, Shankar, et al.
Publicado: (2015)

A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic Pain
por: Song, Gyun Jee, et al.
Publicado: (2019)

The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate‐Exacerbated eosinophilic asthma model
por: Kim, Seo‐Hee, et al.
Publicado: (2023)

Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR)
por: Vrzal, Radim, et al.
Publicado: (2023)

The aryl hydrocarbon receptor at the forefront of host‐microbe interactions in the skin: A perspective on current knowledge gaps and directions for future research and therapeutic applications
por: van den Bogaard, Ellen H., et al.
Publicado: (2021)

Metabolomics Reveals Aryl Hydrocarbon Receptor Activation Induces Liver and Mammary Gland Metabolic Dysfunction in Lactating Mice
por: Belton, Kerry R., et al.
Publicado: (2018)

Induction of AHR Signaling in Response to the Indolimine Class of Microbial Stress Metabolites
por: Patel, Dhwani, et al.
Publicado: (2023)

Aryl hydrocarbon receptor (AhR) reveals evidence of antagonistic pleiotropy in the regulation of the aging process
por: Salminen, Antero
Publicado: (2022)

Persistent Organic Pollutants Modify Gut Microbiota–Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation
por: Zhang, Limin, et al.
Publicado: (2015)

Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
por: Khateb, Mamduh, et al.
Publicado: (2012)

Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells
por: Kim, Sung Hyun, et al.
Publicado: (2018)

Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells
por: Kim, Sung Hyun, et al.
Publicado: (2019)

Distinct Roles for Aryl Hydrocarbon Receptor Nuclear Translocator and Ah Receptor in Estrogen-Mediated Signaling in Human Cancer Cell Lines
por: Labrecque, Mark P., et al.
Publicado: (2012)

Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric Pathogenesis
por: Zhu, Renfei, et al.
Publicado: (2018)

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
por: Ciolino, H P, et al.
Publicado: (1999)

Fluoranthene-Induced Cytotoxicity and Direct Effect of Aryl Hydrocarbon Receptor Antagonist on Hematopoietic Stem Cell Differentiation
por: Yang, Seung-Hyun, et al.
Publicado: (2019)

Monoterpenoid aryl hydrocarbon receptor allosteric antagonists protect against ultraviolet skin damage in female mice
por: Ondrová, Karolína, et al.
Publicado: (2023)

The aryl hydrocarbon receptor in tumor immunity
por: Platten, Michael, et al.
Publicado: (2012)

Antioxidant Functions of the Aryl Hydrocarbon Receptor
por: Dietrich, Cornelia
Publicado: (2016)

Aryl Hydrocarbon Receptor and Stem Cells
por: Gasiewicz, Thomas A., et al.
Publicado: (2017)

The Aryl Hydrocarbon Receptor and Tumor Immunity
por: Xue, Ping, et al.
Publicado: (2018)

The Aryl Hydrocarbon Receptor and the Nervous System
por: Juricek, Ludmila, et al.
Publicado: (2018)

The aryl hydrocarbon receptor in liver inflammation
por: Carambia, Antonella, et al.
Publicado: (2021)

Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications
por: Faber, Samantha C., et al.
Publicado: (2022)

Contribution of Circulating Host and Microbial Tryptophan Metabolites Toward Ah Receptor Activation
por: Morgan, Ethan W, et al.
Publicado: (2023)

Memorandum 351
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1983)

An Increased Level of Aryl Hydrocarbon Receptor in Patients with Pancreatic Cancer
por: Masoudi, Sahar, et al.
Publicado: (2019)

Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists
por: Howard, Gregory J., et al.
Publicado: (2010)

Imatinib and GNF-5 Exhibit an Inhibitory Effect on Growth of Hepatocellar Carcinoma Cells by Downregulating S-phase Kinase-associated Protein 2
por: Zhang, Haibo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aa42ocrbqh6f9t57nd70gig23p